285 related articles for article (PubMed ID: 27292629)
1. Impact and persistence of cirrhotic cardiomyopathy after liver transplantation.
Sonny A; Ibrahim A; Schuster A; Jaber WA; Cywinski JB
Clin Transplant; 2016 Sep; 30(9):986-93. PubMed ID: 27292629
[TBL] [Abstract][Full Text] [Related]
2. Diastolic Dysfunction in Liver Cirrhosis: Prognostic Predictor in Liver Transplantation?
Carvalheiro F; Rodrigues C; Adrego T; Viana J; Vieira H; Seco C; Pereira L; Pinto F; Eufrásio A; Bento C; Furtado E
Transplant Proc; 2016; 48(1):128-31. PubMed ID: 26915857
[TBL] [Abstract][Full Text] [Related]
3. Pediatric cirrhotic cardiomyopathy: Impact on liver transplant outcomes.
Junge N; Junge C; Schröder J; Pfister ED; Leiskau C; Hohmann D; Beerbaum P; Baumann U
Liver Transpl; 2018 Jun; 24(6):820-830. PubMed ID: 29637720
[TBL] [Abstract][Full Text] [Related]
4. Cirrhotic Cardiomyopathy After Transplantation: Neither the Transient Nor Innocent Bystander.
Izzy M; Oh J; Watt KD
Hepatology; 2018 Nov; 68(5):2008-2015. PubMed ID: 29672903
[TBL] [Abstract][Full Text] [Related]
5. Pre-transplant renal impairment predicts posttransplant cardiac events in patients with liver cirrhosis.
Josefsson A; Fu M; Björnsson E; Castedal M; Kalaitzakis E
Transplantation; 2014 Jul; 98(1):107-14. PubMed ID: 24621533
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of cirrhotic cardiomyopathy and its relationship with serum pro-brain natriuretic peptide, hepatorenal syndrome, spontaneous bacterial peritonitis, and mortality.
Kapoor N; Mehta V; Singh B; Karna R; Kumar S; Kar P
Indian J Gastroenterol; 2020 Oct; 39(5):481-486. PubMed ID: 33188455
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and outcome of diastolic dysfunction in liver transplantation recipients.
Raevens S; De Pauw M; Geerts A; Berrevoet F; Rogiers X; Troisi RI; Van Vlierberghe H; Colle I
Acta Cardiol; 2014 Jun; 69(3):273-80. PubMed ID: 25029872
[TBL] [Abstract][Full Text] [Related]
8. Systolic heart failure after liver transplantation: Incidence, predictors, and outcome.
Sonny A; Govindarajan SR; Jaber WA; Cywinski JB
Clin Transplant; 2018 Mar; 32(3):e13199. PubMed ID: 29323769
[TBL] [Abstract][Full Text] [Related]
9. Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation.
Khemakanok K; Khositseth A; Treepongkaruna S; Teeraratkul S; Pansrimangkorn W; Leelaudomlipi S; Bunmee U; Sriphojanart S
Hepatol Int; 2016 May; 10(3):518-24. PubMed ID: 26462482
[TBL] [Abstract][Full Text] [Related]
10. Cirrhotic cardiomyopathy: Implications for liver transplantation.
Liu H; Jayakumar S; Traboulsi M; Lee SS
Liver Transpl; 2017 Jun; 23(6):826-835. PubMed ID: 28407402
[TBL] [Abstract][Full Text] [Related]
11. Markedly prolonged QTc interval in end-stage liver disease and risk of 30-day cardiovascular event after liver transplant.
Kim KS; Kwon HM; Jung KW; Sang BH; Moon YJ; Kim B; Jun IG; Song JG; Hwang GS
J Gastroenterol Hepatol; 2021 Mar; 36(3):758-766. PubMed ID: 32804412
[TBL] [Abstract][Full Text] [Related]
12. Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase.
Zardi EM; Zardi DM; Chin D; Sonnino C; Dobrina A; Abbate A
J Cardiol; 2016 Feb; 67(2):125-30. PubMed ID: 26074443
[TBL] [Abstract][Full Text] [Related]
13. Effect of liver transplantation on QT-interval prolongation and impact on mortality.
Ko J; Koshy AN; Han HC; Weinberg L; Gow P; Testro A; Lim HS; Farouque O; Teh AW
Int J Cardiol; 2021 Mar; 326():158-163. PubMed ID: 33186663
[TBL] [Abstract][Full Text] [Related]
14. Diastolic dysfunction in cirrhosis.
Møller S; Wiese S; Halgreen H; Hove JD
Heart Fail Rev; 2016 Sep; 21(5):599-610. PubMed ID: 27075496
[TBL] [Abstract][Full Text] [Related]
15. Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: A change in the current paradigm.
Koshy AN; Gow PJ; Testro A; Teh AW; Ko J; Lim HS; Han HC; Weinberg L; VanWagner LB; Farouque O
Am J Transplant; 2021 Jun; 21(6):2240-2245. PubMed ID: 33453141
[TBL] [Abstract][Full Text] [Related]
16. Cirrhotic cardiomyopathy is less prevalent in patients with Budd-Chiari syndrome than cirrhosis of liver.
Shukla A; Bhatt P; Gupta DK; Modi T; Patel J; Phadke M; Rathod K; Meshram M; Bhatia SJ
Indian J Gastroenterol; 2017 Nov; 36(6):474-480. PubMed ID: 29368192
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Cirrhosis and Prescription Medications on QTc Interval Before and After Liver Transplantation.
Santeusanio AD; Dunsky KG; Pan S; Schiano TD
J Pharm Pract; 2019 Feb; 32(1):48-53. PubMed ID: 29092657
[TBL] [Abstract][Full Text] [Related]
18. Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study.
Sampaio F; Pimenta J; Bettencourt N; Fontes-Carvalho R; Silva AP; Valente J; Bettencourt P; Fraga J; Gama V
Liver Int; 2013 Sep; 33(8):1158-65. PubMed ID: 23617332
[TBL] [Abstract][Full Text] [Related]
19. An update on cirrhotic cardiomyopathy.
Møller S; Danielsen KV; Wiese S; Hove JD; Bendtsen F
Expert Rev Gastroenterol Hepatol; 2019 May; 13(5):497-505. PubMed ID: 30802157
[TBL] [Abstract][Full Text] [Related]
20. Electrocardiographic and echocardiographic changes in patients undergoing liver transplant stratified by outcomes.
Gajanana D; Gupta S; Koshkelashvili N; Rubio M; Bhalla V; Amanullah A
Int J Cardiol; 2016 Nov; 223():699-700. PubMed ID: 27568992
[No Abstract] [Full Text] [Related]
[Next] [New Search]
